Skip to main content
Cancer Explained
Donate
Beginner 6 min readSource checked

When Kidney Cancer Comes Back: Recurrence Questions

What to ask when kidney cancer may have returned, including biopsy, biomarkers, treatment goals, and second opinions.

This is general education — it cannot tell you what to do in your situation.

Instructions and urgent-contact thresholds vary by treatment and care team. If you are in treatment, follow the instructions your oncology team gave you, and contact them about any new or worsening symptom. If you think you may be having a medical emergency, call your local emergency number.

NCI source

NCI — Renal Cell Cancer Treatment (PDQ) Patient Version

Four adults with daypacks walk a dirt trail through green coastal hills, talking and smiling.
Hiking With Friends

Key fact

NCI says renal cell cancer can recur many years after initial treatment, so follow-up is a long game rather than a two-year window.

The short answer

NCI says renal cell cancer can come back many years after initial treatment, and that the treatment for a recurrence depends on where it has come back. First-line options for stage IV and recurrent disease include several immunotherapy and targeted-drug combinations.

  • NCI says renal cell cancer can recur many years after initial treatment, so follow-up is a long game rather than a two-year window.

  • Where the cancer has come back is one factor in treatment, alongside the cell type of the tumour, your risk group, how fast it is moving, what you have had before, and your other health.

  • NCI's list of first-line options for stage IV and recurrent renal cell cancer runs to several immunotherapy and targeted combinations; a list is not a ranking, and choosing between them is a specialist judgement.

  • Single targeted drugs, surgery and radiation also appear on the same list, including some older agents now used mainly in particular circumstances.

Choose how you want to understand this

The full explanation.

Kidney cancer can come back many years later

NCI says plainly that renal cell cancer can recur many years after the first treatment. That is unusual among cancers, and it matters.

It means a new finding a decade after your nephrectomy is not automatically something else. It also means follow-up is a long game, not a two-year sprint.

Making sure the spot is really cancer

Scar tissue sits in the surgical bed. Small lung nodules are common in people who never had cancer.

NCI's approach to a suspected return is to run tests to work out where the cancer has come back. Ask whether a biopsy is needed before anything changes.

Ask what the radiologist actually wrote, not just the summary line.

Where it came back is one of several things that shape the plan

NCI says treatment for recurrent renal cell cancer depends on where it has come back, and that much is straightforwardly true. Cancer that returns in the kidney bed is a different problem from cancer in the lungs, bone, liver or brain.

But location alone does not settle it. The cell type matters: most kidney cancers are clear cell, and the drug evidence is largely built on those, so a non-clear-cell tumour is a different conversation. So does your risk group, how fast the disease is moving, whether you have symptoms, what you were given before, and whether you are well enough for a combination.

Ask where it is, and then ask what else is going into the decision.

The drug list for advanced and recurrent disease

NCI lists several first-line options for stage IV and recurrent renal cell cancer. Two immunotherapy drugs may be paired, as in ipilimumab plus nivolumab. Immunotherapy may instead be paired with a targeted drug, as in pembrolizumab with axitinib or lenvatinib, or nivolumab with cabozantinib.

Single targeted drugs are also on the list, among them cabozantinib, sunitinib and pazopanib, and so is surgery to remove the kidney in some situations. Read that as a catalogue, not a menu you order from. The list mixes current standards with older agents now used in narrower circumstances, and it is not ordered by preference. Which of them fits you depends on the cell type, your risk group, your kidney and heart function, and what you have already had.

Surgery and radiation still appear on that list. A form of focused radiation called stereotactic ablative body radiation therapy is used in some cases.

Questions for the kidney cancer team

  • Is this a recurrence, or scar tissue in the old surgical bed?
  • Do we need a biopsy to be certain before we change the plan?
  • Where exactly is it, and does that put me in the stage IV group?
  • There is only one spot. Can surgery or focused radiation treat it, instead of drugs?
  • I had pembrolizumab after my nephrectomy. Does that change which immunotherapy you would use now?
  • My kidney function is lower since surgery. Is contrast dye still safe for my scans?
  • Which of the combinations on the NCI list fits me, and why that one?

When a second opinion is worth the trip

Kidney cancer has several first-line combinations and no single right answer. That is exactly the situation where a second oncologist may reasonably choose differently.

It is also worth it if surgery on a single recurrent spot is being considered.

Scans, contrast and the kidney you still have

Contrast dye is filtered by the kidneys. After a nephrectomy you have less filtering capacity.

Ask what your current kidney function is. Ask whether MRI or a non-contrast scan can do the same job.

When to get help sooner

Recurrence is usually found on a scan, not by a symptom. Still, a few things should not wait for the next scheduled visit.

  • Call 911 or go to an emergency department if you have sudden or severe difficulty breathing, chest pain or pain in the upper back, or a racing heart. The NHS puts those in its emergency group, and kidney cancer that has spread most often goes to the lungs. Go straight in as well for heavy bleeding in the urine with clots you cannot pass, for sudden severe back or flank pain, or for new weakness, numbness in the legs, or trouble controlling your bladder or bowels, which can follow spread to the spine.
  • Call your care team the same day if you see blood in your urine, or if urine turns smelly or cloudy, if it hurts to pass or you suddenly need to pass it more often, if you have pain in your back under the ribs that will not go away, or if you find a new lump or swelling in the back, under the ribs, or in the neck. The NHS puts all of those in its urgent group, and NCI lists blood in the urine first among the signs of renal cell cancer. The NHS notes the same picture can be a kidney infection, which is itself serious if it is left.
  • Call your care team within a day or two if you have bone pain that is worse at night, a persistent cough, a temperature that will not settle, drenching night sweats, or weight loss you did not intend. On targeted therapy or immunotherapy, report new diarrhoea, a skin rash, or breathlessness in the same window. These are the drugs listed above, and their reactions are handled faster when caught early.

More on this stage: Local vs Distant Recurrence, Cancer Staging, Clinical Trial vs Standard Treatment, and Questions to Ask Your Doctor.

Where this comes from

Words to know

Tap any term to see what it means.

Browse the full glossary →

An older man, woman in a headscarf, and another woman talk together on a home sofa

Common questions

Can kidney cancer really come back after many years?

Yes. NCI states directly that renal cell cancer can recur many years after initial treatment. A new finding a decade after a nephrectomy is not automatically something unrelated.

What decides the treatment if it has come back?

Several things at once. NCI says treatment depends on where the cancer has come back, and that is real, but it is not the whole of it. Whether the tumour is clear cell or another type, which risk group you fall into, how quickly the disease is moving, what symptoms you have, what treatment you had before, and your other health all feed into the choice.

Is there more than one reasonable first-line choice?

Yes, which is why a second opinion is often worth it. NCI lists several immunotherapy pairs, immunotherapy plus targeted therapy pairs, and single targeted drugs as first-line options for stage IV and recurrent disease.

Questions to ask your doctor

Being prepared helps you get the most out of your appointments. Save or print these questions.

Open my question list

Tap a question to save it to your list (kept on this device).

Your next step

Turn this topic into questions for your next appointment.

Build a question list
Human Connection Layer

Speak With Trained Specialists & Human Navigators

Cancer Explained provides educational guidance, but does not replace trained specialists, social workers, or your medical team.

Free & Confidential

Talk to a trained cancer information specialist

Free, confidential assistance from NCI Cancer Information Service via phone, chat, or email.

Contact your oncology team

Locate after-hours contact numbers, portal messages, or urgent triage phone lines.

Find a patient navigator

Get one-on-one help with appointments, logistics, translation, and care coordination.

Find a genetic counselor

Discuss inherited mutation risk, family history, and genetic testing options.

Find an oncology social worker

Access emotional counseling, family support groups, and mental health resources.

Find a financial navigator

Locate copay assistance foundations, grant programs, and lodging/travel support.

Find a clinical-trial specialist

Search matching studies and speak with NCI trial information specialists.

Get urgent help

Immediate emergency guidance for fever (>100.4°F during chemo), severe pain, or shortness of breath.

Help Us Improve This Guide

Did this explanation answer your question and help you determine your next step?

Know someone who needs this?

Plenty of people are looking for something like this and do not know where to start. If this would help a friend or someone you love, send it on — we have written an opening line so you do not have to stare at an empty message. You can change every word of it.

Email itText itWhatsApp

Your message is written and sent in your own email or messaging app — we never see who you send it to, and nothing is added to any list.

Plain-language explanation of the published sources cited on this page. AI-assisted, source-checked, not clinician-reviewed.

Sources last checked: 2026-08-13 what this meansLast updated: 2026-08-19Next planned review: 2028-07-30

How this page was created

Cancer Explained does not originate medical claims. Every page restates guidance already published by the National Cancer Institute, the CDC, the USPSTF and the FDA, in plain language, with the source cited so you can check the original yourself. AI does the translating and organizing; automated checks test claims, citations, clarity and safety before anything publishes. We do not employ clinicians and do not intend to — our work is translation and navigation, not clinical judgment. Nothing here is personal medical advice, and no page can account for your particular situation.

Editorial status — Source checked. This page was written with AI assistance and checked line by line against the sources listed on it. That confirms the sources support what the page says. It is not a medical review, and it does not confirm the page is complete or right for your situation.

High-risk topic — talk to your care team. This topic can involve urgent, individual medical decisions. This page is general education only: it cannot tell you whether your situation is an emergency or what you personally should do. Follow your oncology team's instructions and contact them for individual guidance.

Human medical review: not completed. Pages here are not signed off by a clinician before they publish. That is not an oversight we are quietly working around: we restate published guidance and cite it, so the authority belongs to the source rather than to us, and every page names where its claims come from — you can verify us instead of trusting us. Where a volunteer clinician has reviewed a page, their name and credentials appear on it; where no name appears, no clinician has checked it. We are glad to have reviewers and are recruiting them, and we do not hold pages back waiting for one. Use this site to understand your situation and to ask better questions of the people treating you.

Our editorial processHow we use AIReport an error

How this page was created

Cancer Explained does not originate medical claims. Every page restates guidance already published by the National Cancer Institute, the CDC, the USPSTF and the FDA, in plain language, with the source cited so you can check the original yourself. AI does the translating and organizing; automated checks test claims, citations, clarity and safety before anything publishes. We do not employ clinicians and do not intend to — our work is translation and navigation, not clinical judgment. Nothing here is personal medical advice, and no page can account for your particular situation.

Editorial status: Source checked This page was written with AI assistance and checked line by line against the sources listed on it. That confirms the sources support what the page says. It is not a medical review, and it does not confirm the page is complete or right for your situation.

Human medical review: not completed. Pages here are not signed off by a clinician before they publish. That is not an oversight we are quietly working around: we restate published guidance and cite it, so the authority belongs to the source rather than to us, and every page names where its claims come from — you can verify us instead of trusting us. Where a volunteer clinician has reviewed a page, their name and credentials appear on it; where no name appears, no clinician has checked it. We are glad to have reviewers and are recruiting them, and we do not hold pages back waiting for one. Use this site to understand your situation and to ask better questions of the people treating you.

Read more about our editorial process, our use of AI, and our corrections policy.

Spotted a problem? Report an error — a factual mistake, broken or outdated source, confusing wording, or anything that seems unsafe. Please do not include names, medical record numbers, dates of birth, addresses, or other identifying medical information in your report.

After using this page, do you understand what to do next?

Anonymous — we only record the answer, never who gave it.